These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2104184

  • 1. Autoimmune angioedema: a new role for autoantibody in disease pathogenesis.
    Jackson J, Feighery C.
    Autoimmunity; 1990; 7(2-3):181-7. PubMed ID: 2104184
    [Abstract] [Full Text] [Related]

  • 2. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J, Sim RB, Whaley K, Feighery C.
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [Abstract] [Full Text] [Related]

  • 3. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
    Alsenz J, Loos M.
    Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
    [Abstract] [Full Text] [Related]

  • 4. Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor.
    Kleiner GI, Giclas P, Stadtmauer G, Cunningham-Rundles C.
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):461-4. PubMed ID: 11345293
    [Abstract] [Full Text] [Related]

  • 5. Autoimmune C1 inhibitor deficiency: report of eight patients.
    Cicardi M, Bisiani G, Cugno M, Späth P, Agostoni A.
    Am J Med; 1993 Aug; 95(2):169-75. PubMed ID: 8356982
    [Abstract] [Full Text] [Related]

  • 6. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.
    Alsenz J, Lambris JD, Bork K, Loos M.
    J Clin Invest; 1989 Jun; 83(6):1794-9. PubMed ID: 2723058
    [Abstract] [Full Text] [Related]

  • 7. Urticaria, angioedema, and autoimmunity.
    Zuraw BL.
    Clin Lab Med; 1997 Sep; 17(3):559-69. PubMed ID: 9316773
    [Abstract] [Full Text] [Related]

  • 8. C1-inhibitor deficiency and angioedema.
    Carugati A, Pappalardo E, Zingale LC, Cicardi M.
    Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
    [Abstract] [Full Text] [Related]

  • 9. Autoimmune C1 inhibitor deficiency and angioedema.
    Valsecchi R, Reseghetti A, Pansera B, Di Landro A.
    Dermatology; 1997 Aug; 195(2):169-72. PubMed ID: 9310729
    [Abstract] [Full Text] [Related]

  • 10. Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.
    Ponce IM, Caballero T, Reche M, Piteiro AB, López-Serrano MC, Fontán G, López-Trascasa M.
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):632-7. PubMed ID: 12086372
    [Abstract] [Full Text] [Related]

  • 11. Autoimmune acquired form of angioedema that responded to danazol therapy.
    Higa S, Hirata H, Minami S, Hashimoto S, Suemura M, Saeki Y, Kawase I, Tanaka T.
    Intern Med; 2002 May; 41(5):398-402. PubMed ID: 12058892
    [Abstract] [Full Text] [Related]

  • 12. Pathogenetic and clinical aspects of C1 inhibitor deficiency.
    Cicardi M, Bergamaschini L, Cugno M, Beretta A, Zingale LC, Colombo M, Agostoni A.
    Immunobiology; 1998 Aug; 199(2):366-76. PubMed ID: 9777420
    [Abstract] [Full Text] [Related]

  • 13. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid.
    Cugno M, Cicardi M, Agostoni A.
    J Allergy Clin Immunol; 1994 May; 93(5):870-6. PubMed ID: 8182230
    [Abstract] [Full Text] [Related]

  • 14. Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor.
    Malbran A, Hammer CH, Frank MM, Fries LF.
    J Allergy Clin Immunol; 1988 Jun; 81(6):1199-204. PubMed ID: 2454251
    [Abstract] [Full Text] [Related]

  • 15. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol.
    Pappalardo E, Zingale LC, Cicardi M.
    Immunol Lett; 2003 May 01; 86(3):271-6. PubMed ID: 12706530
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of C1-inhibitor deficiency.
    Pappalardo E, Zingale LC, Terlizzi A, Zanichelli A, Folcioni A, Cicardi M.
    Immunobiology; 2002 Sep 01; 205(4-5):542-51. PubMed ID: 12396014
    [Abstract] [Full Text] [Related]

  • 17. ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients.
    Engel R, Rensink I, Roem D, Brouwer M, Kalei A, Perry D, Zeerleder S, Wouters D, Hamann D.
    J Immunol Methods; 2015 Nov 01; 426():114-9. PubMed ID: 26318839
    [Abstract] [Full Text] [Related]

  • 18. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients.
    Agostoni A, Cicardi M.
    Medicine (Baltimore); 1992 Jul 01; 71(4):206-15. PubMed ID: 1518394
    [Abstract] [Full Text] [Related]

  • 19. Angioneurotic edema with acquired C1- inhibitor deficiency and autoantibody to C1- inhibitor: response to plasmapheresis and cytotoxic therapy.
    Donaldson VH, Bernstein DI, Wagner CJ, Mitchell BH, Scinto J, Bernstein IL.
    J Lab Clin Med; 1992 Apr 01; 119(4):397-406. PubMed ID: 1583391
    [Abstract] [Full Text] [Related]

  • 20. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema.
    Cicardi M, Beretta A, Colombo M, Gioffré D, Cugno M, Agostoni A.
    Clin Exp Immunol; 1996 Dec 01; 106(3):475-80. PubMed ID: 8973615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.